v3.24.2.u1
Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income Loss [Member]
Accumulated Deficit [Member]
Balance at Dec. 31, 2022 $ 176,600 $ 2 $ 288,814   $ (112,216)
Balance (in Shares) at Dec. 31, 2022   17,403,315      
Issuance of common stock upon exercise of stock options 1,067   1,067    
Issuance of common stock upon exercise of stock options (in Shares)   74,753      
Vesting of restricted common stock (in Shares)   958      
Stock-based compensation expense 1,024   1,024    
Sale of common stock in registered direct offering 34,148   34,148    
Sale of common stock in registered direct offering, (in shares)   1,488,166      
Sale of pre-funded warrants in registered direct offering 28,206   28,206    
Sale of common stock in at-the-market offerings 14,591   14,591    
Sale of common stock in at-the-market offerings, (in shares)   608,050      
Net Income (Loss) (22,781)       (22,781)
Balance at Mar. 31, 2023 232,855 $ 2 367,850   (134,997)
Balance (in Shares) at Mar. 31, 2023   19,575,242      
Balance at Dec. 31, 2022 176,600 $ 2 288,814   (112,216)
Balance (in Shares) at Dec. 31, 2022   17,403,315      
Foreign currency translation adjustments 0        
Net Income (Loss) (38,728)        
Balance at Jun. 30, 2023 371,219 $ 2 522,161   (150,944)
Balance (in Shares) at Jun. 30, 2023   22,850,894      
Balance at Mar. 31, 2023 232,855 $ 2 367,850   (134,997)
Balance (in Shares) at Mar. 31, 2023   19,575,242      
Issuance of common stock upon exercise of stock options 242   242    
Issuance of common stock upon exercise of stock options (in Shares)   41,475      
Vesting of restricted common stock (in Shares)   958      
Stock-based compensation expense 1,309   1,309    
Foreign currency translation adjustments 0        
Sale of common stock in follow on public offering, Shares   3,015,919      
Sale of common stock in In follow on public offering 138,508   138,508    
Sale of pre-funded warrants in follow-on public offering 9,373   9,373    
Sale of common stock in at-the-market offerings 4,879   4,879    
Sale of common stock in at-the-market offerings, (in shares)   217,300      
Net Income (Loss) (15,947)       (15,947)
Balance at Jun. 30, 2023 371,219 $ 2 522,161   (150,944)
Balance (in Shares) at Jun. 30, 2023   22,850,894      
Balance at Dec. 31, 2023 345,121 $ 2 533,764   (188,645)
Balance (in Shares) at Dec. 31, 2023   24,360,233      
Issuance of common stock upon exercise of stock options 806   806    
Issuance of common stock upon exercise of stock options (in Shares)   95,467      
Stock-based compensation expense 4,058   4,058    
Sale of common stock in at-the-market offerings 14,790   14,790    
Sale of common stock in at-the-market offerings, (in shares)   234,449      
Issuance of common stock under employee stock purchase plan 245   245    
Issuance of common stock under employee stock purchase plan (in shares)   5,736      
Net Income (Loss) (26,949)       (26,949)
Balance at Mar. 31, 2024 338,071 $ 2 553,663   (215,594)
Balance (in Shares) at Mar. 31, 2024   24,695,885      
Balance at Dec. 31, 2023 $ 345,121 $ 2 533,764   (188,645)
Balance (in Shares) at Dec. 31, 2023   24,360,233      
Issuance of common stock upon exercise of stock options (in Shares) 163,579        
Foreign currency translation adjustments $ 6        
Net Income (Loss) (53,301)        
Balance at Jun. 30, 2024 488,829 $ 3 730,832 $ (60) (241,946)
Balance (in Shares) at Jun. 30, 2024   29,707,997      
Balance at Mar. 31, 2024 338,071 $ 2 553,663   (215,594)
Balance (in Shares) at Mar. 31, 2024   24,695,885      
Issuance of common stock upon exercise of stock options 567   567    
Issuance of common stock upon exercise of stock options (in Shares)   68,112      
Stock-based compensation expense 4,091   4,091    
Sale of common stock in registered direct offering 172,512 $ 1 172,511    
Sale of common stock in registered direct offering, (in shares)   4,944,000      
Foreign currency translation adjustments 6     6  
Unrealized loss on marketable securities (66)     (66)  
Net Income (Loss) (26,352)       (26,352)
Balance at Jun. 30, 2024 $ 488,829 $ 3 $ 730,832 $ (60) $ (241,946)
Balance (in Shares) at Jun. 30, 2024   29,707,997